Epigenetic regulation of T cell lineages in skin and blood following hematopoietic stem cell transplantation

Clin Immunol. 2023 Mar:248:109245. doi: 10.1016/j.clim.2023.109245. Epub 2023 Jan 23.

Abstract

Allogeneic hematopoietic stem-cell transplantation (HSCT) seeks to reconstitute the host's immune system from donor stem cells. The success of HSCT is threatened by complications including leukemia relapse or graft-versus-host-disease (GvHD). To investigate the underlying regulatory processes in central and peripheral T cell recovery, we performed sequential multi-omics analysis of T cells of the skin and blood during HSCT. We detected rapid effector T cell reconstitution, while emergence of regulatory T cells was delayed. Epigenetic and gene-regulatory programs were associated with recovering T cells and diverged greatly between skin and blood T cells. The BRG1/BRM-associated factor chromatin remodeling complex and histone deacetylases (HDACs) were epigenetic regulators involved in restoration of T cell homeostasis after transplantation. In isolated T cells of patients after HSCT, we observed class I HDAC-inhibitors to modulate their dysbalance. The present study highlights the importance of epigenetic regulation in the recovery of T cells following HSCT.

Keywords: Epigenetic regulation; Hematopoietic stem cell transplantation; Histone deacetylases; T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Lineage
  • Epigenesis, Genetic
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia*